Company intelligence / Profile preview

NovelStem International Corp.

Boca Raton, Florida, United Statesnovelstem.com ↗

Ownership: Private
Development stage: Preclinical

Overview

NovelStem is developing diagnostic technology that can predict patients' resistance to chemotherapy, allowing for targeted cancer treatments with the potential to reduce incidents of chemotherapy resistance.

Therapeutic areas: Oncology
Modalities: Stem cell-based diagnostics
Industry: Molecular Diagnostics

Partnerships

NewStem Ltd. (33% ownership stake)

Beyond the preview

Go deeper on NovelStem International Corp..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NovelStem International Corp..

Explore the full profile